Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 71.40
-1.70 (-2.33%)
Feb 11, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 8.96 billion as of February 11, 2026. Its market cap has decreased by -37.34% in one year.
Market Cap
8.96B
Enterprise Value
7.43B
Revenue
37.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
71.40
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 8.96B, an increase of 1.09%. That is a compound annual growth rate of 0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 8.96B | -15.10% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 13.00B |
| Medigen Vaccine Biologics | 11.85B |
| TCM Biotech International | 10.78B |
| PharmaEngine | 9.14B |
| TaiGen Biopharmaceuticals Holdings | 8.76B |
| Acepodia | 8.03B |
| Adimmune | 7.67B |
| Mycenax Biotech | 7.09B |